Predictors For Transosseous Maxillary Sinus Lift Complications
Launched by UNIVERSITY OF BAGHDAD · Jun 3, 2025
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand what factors might lead to complications after a specific dental procedure called a transosseous maxillary sinus lift. This procedure is often needed for patients who want dental implants but have insufficient bone height in their upper jaw. The study will examine various factors, such as how much bone is left, the thickness of the sinus membrane, and the density of the bone, to help doctors better plan the surgery and reduce risks for patients.
To be eligible for this trial, participants need to be adults who are in good health and require dental implants in the back part of their upper jaw, specifically those who have less than 6 mm of bone height left. They should not have any serious health issues that could affect healing, like uncontrolled diabetes, and they should not have a history of chronic sinus problems. Participants can expect to undergo assessments related to their bone and sinus health, and their information will help improve future care for people needing similar procedures. If you have a history of smoking or have had previous sinus surgeries, you may not be eligible for this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1- Patients requiring dental implants in the posterior maxilla with a residual bone height of \< 6 mm.
- • 2- Good general health and absence of systemic conditions affecting bone healing (e.g., uncontrolled diabetes, osteoporosis).
- • 3- No history of chronic sinusitis or other significant sinus pathologies
- Exclusion Criteria:
- • 1- Severe periodontal disease. 2- Residual bone height \> 6 mm. 3- History of previous sinus lift procedures or other maxillofacial surgeries. 4- Smokers.
About University Of Baghdad
The University of Baghdad, a leading academic institution in Iraq, is committed to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive network of experts and state-of-the-art facilities to conduct rigorous clinical studies. The institution aims to contribute valuable insights into various health conditions, fostering an environment of scientific inquiry and ethical research practices that ultimately enhance patient care and public health in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baghdad, Bab Almodaum, Iraq
Baghdad, Mansour, Iraq
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported